The training platform for healthcare professionals, Invivox, has raised 7 million euros from Educapital, a fund specializing in the financing of education and training, MACSF and the historical investors ISAI and Bpifrance. Through this operation, Invivox continues its development (recruitment of 30 people) and accelerates its R&D.
Created in 2016, Invivox is the only healthcare platform that centralizes and shares training content for healthcare professionals in France and abroad. Today, with 250,000 users, Invivox holds a leading position in continuing medical education in France.
Jérémie Swiecznik, partner, and Maxim Khlopotin, associate, accompanied Bpifrance and Isai in their investment in Invivox (Series B).
Created in 2016, Invivox is the only healthcare platform that centralizes and shares training content for healthcare professionals in France and abroad. Today, with 250,000 users, Invivox holds a leading position in continuing medical education in France.
Jérémie Swiecznik, partner, and Maxim Khlopotin, associate, accompanied Bpifrance and Isai in their investment in Invivox (Series B).